360 High-Risk Vulnerability Immunization Tool V2.0 vs Automox Security Platform: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Automox Security Platform: Cloud-based endpoint mgmt platform for patching, config, & software deployment. built by Automox. Core capabilities include Automated patch management for Windows, macOS, and Linux, Role-based access control (RBAC), Multi-factor authentication (MFA)..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Automox Security Platform differentiates with Automated patch management for Windows, macOS, and Linux, Role-based access control (RBAC), Multi-factor authentication (MFA).

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Automox Security Platform is developed by Automox. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Automox Security Platform serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Patch Management. Review the feature comparison above to determine which fits your requirements.